NIH Wants Trial Sites to Use a Single IRB

Drug Industry Daily
A A
Sponsors of multi-site clinical trials should take greater advantage of their ability to use a single institutional review board, says a draft policy that seeks to require the practice for all NIH-supported domestic trial sites.

To View This Article:

Login

Subscribe To Drug Industry Daily